Skip to main content
. 2016 Sep 24;8(2):3581–3590. doi: 10.18632/oncotarget.12240

Table 3. Adverse events after 30 cycles of .

Adverse event Latent Sub-acute
All grades Grade 3 All grades Grade 3
Renal
Glomerular filtration rate (GFR) 8 (53%) 0 1 (7%) 0
Tubular extraction rate (TER) 2 (13%) 0 - -
Hyperkalemia 4 (27%) 0 0 0
Hematologic
Anemia 3 (20%) 0 9 (60%) 1 (7%)
Thrombocytopenia 2 (13%) 0 1 (7%) 0
Leukocytes 7 (47%) 1 (7%) 1 (7%) 0
Liver
Bilirubin 0 0 1 (7%) 0
AST/ALT 2 (13%) 0 1 (7%) 0
Other
Fatigue 5 (33%) 0 0 0
Dry mouth 7 (47%) 0 0 0
Nausea 5 (33%) 1 (7%) 0 0
Dysgeusia 3 (20%) 0 0 0

Absolute number of adverse events (%) are given.